1703149975369_m.jpg)
Apple appears to be in trouble since it is presently facing legal action for infringement of the Spo2 patent about its flagship Watch Ultra 2 and Apple Watch 9 series. Due to a patent disagreement, Apple attempted to postpone the import and sales ban on the Watch Series 9 and Watch Ultra 2, but the US International Trade Commission (ITC) rejected their request.
The US ITC stated that it has "determined to deny the respondentâ€TMs motion to stay remedial orders pending appeal and/or in light of potential government shutdown" in a document made late on Wednesday.
The blood oxygen sensor (SpO2 sensor) technology used in the Watchâ€TM is at the centre of the protracted patent dispute between Apple and Masimo, a medical technology business. According to an October ITC verdict, the tech giant violated Masimo's patents with its SpO2 sensors.
The Watch Series 9 and Ultra 2 may only be purchased at Apple shops through December 24. On December 26, the import ban will formally take effect. According to sources, Apple is working on software updates that will affect how the Watch detects and displays oxygen saturation.
Additionally, only sales of the Series 9 and Ultra 2 in the US are affected by the restriction; international sales of the watches are unaffected. Masimo's pulse oximeter is well-known. The company claimed that Apple had violated its pulse oximetry technology in two different lawsuits that it had filed.
Apple is "pursuing a range of legal and technical options to ensure that Apple Watch is available to customers," a spokeswoman for the company previously stated. The company "strongly disagrees" with the order. US President Joe Biden has the option to veto the ITC import ban ruling, which is presently going through a presidential review process.